IGF2BP2 Enhances Anti-Angiogenic CRC Therapy | AcademicJobs CN
Discover how SYSU researchers identified IGF2BP2-CEMIP axis to boost anti-angiogenic therapies for colorectal cancer, addressing China's rising CRC burden.
precision-medicineresearch-publication-newssun-yat-sen-university
